Assignee
RANBAXY LAB LTD
IN·120 granted patents·79 pending applications·1,050 citations·filing 1988–2014
Top patents by PatentIndex Score
199 records- 0194US6090809A1-(4-arylpiperazin-1-yl)-ω-[n-(α..omega.-dicarboximido)]-alkanes useful as uro-selective α1 -adrenoceptor blockersRANBAXY LAB LTD·Filed 1998·Granted Jul 18, 2000·53 cites·8 claims
- 0294US6083950A1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockersRANBAXY LAB LTD·Filed 1998·Granted Jul 4, 2000·56 cites·8 claims
- 0392US6673369B2Controlled release formulationRANBAXY LAB LTD·Filed 2002·Granted Jan 6, 2004·60 cites·27 claims
- 0492US6528660B1Process for the production of amorphous atorvastatin calciumRANBAXY LAB LTD·Filed 2000·Granted Mar 4, 2003·37 cites·5 claims
- 0592US6261601B1Orally administered controlled drug delivery system providing temporal and spatial controlRANBAXY LAB LTD·Filed 1998·Granted Jul 17, 2001·121 cites·11 claims
- 0687US9132092B1Pharmaceutical composition of doxycyclineRANBAXY LAB LTD·Filed 2014·Granted Sep 15, 2015·7 cites·12 claims
- 0787US5763646AProcess for manufacturing simvastatin from lovastatin or mevinolinic acidRANBAXY LAB LTD·Filed 1997·Granted Jun 9, 1998·49 cites·23 claims
- 0886US6890957B2Liquid formulation of metforminRANBAXY LAB LTD·Filed 2003·Granted May 10, 2005·21 cites·15 claims
- 0985US6323193B1Bioavailable oral dosage form of cefuroxime axetilRANBAXY LAB LTD·Filed 2000·Granted Nov 27, 2001·21 cites·6 claims
- 1084US6602999B1Amorphous form of cefpodoxime proxetilRANBAXY LAB LTD·Filed 2000·Granted Aug 5, 2003·15 cites·8 claims
- 1184US6565877B1Taste masked compositionsRANBAXY LAB LTD·Filed 2000·Granted May 20, 2003·32 cites·25 claims
- 1283US8378142B2Intermediate compounds and their use in preparation of lacosamideRANBAXY LAB LTD·Filed 2011·Granted Feb 19, 2013·3 cites·1 claims
- 1383US5917058AProcess of lactonization in the preparation of statinsRANBAXY LAB LTD·Filed 1998·Granted Jun 29, 1999·33 cites·11 claims
- 1482US5763653AKey intermediates in the manufacture of simvastatinRANBAXY LAB LTD·Filed 1997·Granted Jun 9, 1998·25 cites·3 claims
- 1581US7956198B2Pharmaceutical compositionsRANBAXY LAB LTD·Filed 2006·Granted Jun 7, 2011·11 cites·9 claims
- 1681US6734307B2Oxazolidinone derivatives as antimicrobialsRANBAXY LAB LTD·Filed 2001·Granted May 11, 2004·14 cites·9 claims
- 1780US8911787B2Stable oral benzimidazole compositions and process of preparation thereofRANBAXY LAB LTD·Filed 2014·Granted Dec 16, 2014·4 cites·16 claims
- 1880US7115281B2Processes for the preparation of oral dosage formulations of modafinilRANBAXY LAB LTD·Filed 2003·Granted Oct 3, 2006·18 cites·13 claims
- 1980US6822119B1Process for the preparation of tolterodineRANBAXY LAB LTD·Filed 2002·Granted Nov 23, 2004·12 cites·11 claims
- 2079US7872140B2Barium salt of benzimidazole derivativeRANBAXY LAB LTD·Filed 2009·Granted Jan 18, 2011·2 cites·10 claims
- 2179US7288562B2Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonistsRANBAXY LAB LTD·Filed 2002·Granted Oct 30, 2007·14 cites·27 claims
- 2278US6956040B2Oxazolidinone piperazinyl derivatives as potential antimicrobialsRANBAXY LAB LTD·Filed 2002·Granted Oct 18, 2005·16 cites·4 claims
- 2377US7482463B2Amorphous form of esomeprazole saltsRANBAXY LAB LTD·Filed 2007·Granted Jan 27, 2009·2 cites·16 claims
- 2477US6420559B11-(4-arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockersRANBAXY LAB LTD·Filed 2000·Granted Jul 16, 2002·5 cites·2 claims
- 2577US6410735B11-(4-arylpiperazin-1-y1)-ω-[N-(α,ω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockersRANBAXY LAB LTD·Filed 2000·Granted Jun 25, 2002·5 cites·2 claims
- 2675US7045618B2Cefpodixime proxetilRANBAXY LAB LTD·Filed 2002·Granted May 16, 2006·7 cites·12 claims
- 2774US7517905B2Substituted azabicyclo hexane derivatives as muscarinic receptor antagonistsRANBAXY LAB LTD·Filed 2003·Granted Apr 14, 2009·7 cites·12 claims
- 2874US6686497B1Synthesis of 3-ethoxy-4-ethoxycarbonyl phenyl acetic acid, a key acid synthon of repaglinideRANBAXY LAB LTD·Filed 2000·Granted Feb 3, 2004·8 cites·18 claims
- 2974US5939564AProcess of lactonization in the preparation of statinsRANBAXY LAB LTD·Filed 1998·Granted Aug 17, 1999·19 cites·10 claims
- 3073US7943794B2Processes for the preparation of intermediates of valsartanRANBAXY LAB LTD·Filed 2009·Granted May 17, 2011·2 cites·14 claims
- 3173US7671216B2Process for preparation of (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium saltRANBAXY LAB LTD·Filed 2006·Granted Mar 2, 2010·3 cites·8 claims
- 3273US7232835B23,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonistsRANBAXY LAB LTD·Filed 2002·Granted Jun 19, 2007·13 cites·24 claims
- 3373US6384213B1Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetilRANBAXY LAB LTD·Filed 2000·Granted May 7, 2002·7 cites·3 claims
- 3472US9393205B2Gastroretentive tabletsRANBAXY LAB LTD·Filed 2013·Granted Jul 19, 2016·1 cites·10 claims
- 3570US8846910B2Matrix metalloproteinase inhibitorsRANBAXY LAB LTD·Filed 2013·Granted Sep 30, 2014·2 cites·3 claims
- 3670US7488748B23,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonistsRANBAXY LAB LTD·Filed 2003·Granted Feb 10, 2009·5 cites·25 claims
- 3769US7825147B2Inhibitors of phosphodiesterase type-IVRANBAXY LAB LTD·Filed 2004·Granted Nov 2, 2010·7 cites·6 claims
- 3869US6833452B2Process for the preparation of highly pure crystalline (R,S)—cefuroxime axetilRANBAXY LAB LTD·Filed 2001·Granted Dec 21, 2004·6 cites·21 claims
- 3969US6586005B1Extended release formulation of etodolacRANBAXY LAB LTD·Filed 2000·Granted Jul 1, 2003·2 cites·8 claims
- 4069US6541511B1Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitorsRANBAXY LAB LTD·Filed 2002·Granted Apr 1, 2003·5 cites·22 claims
- 4169US5621120AProcess for the manufacture of form 1 ranitidine hydrochlorideRANBAXY LAB LTD·Filed 1994·Granted Apr 15, 1997·11 cites·23 claims
- 4268US6420366B11-(4-arylpiperazin-1-yl)-ω-[N-(αω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockersRANBAXY LAB LTD·Filed 2000·Granted Jul 16, 2002·2 cites·5 claims
- 4368US6267986B1Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamineRANBAXY LAB LTD·Filed 1999·Granted Jul 31, 2001·34 cites·18 claims
- 4467US7501443B2Flavaxate derivatives as muscarinic receptor antagonistsRANBAXY LAB LTD·Filed 2002·Granted Mar 10, 2009·5 cites·4 claims
- 4567US7241885B2Process for the isolation of crystalline imipenemRANBAXY LAB LTD·Filed 2002·Granted Jul 10, 2007·4 cites·8 claims
- 4667US7052886B2Process for the isolation of lovastatinRANBAXY LAB LTD·Filed 2001·Granted May 30, 2006·4 cites·11 claims
- 4767US6960356B1Orally administered drug delivery system providing temporal and spatial controlRANBAXY LAB LTD·Filed 1999·Granted Nov 1, 2005·28 cites·41 claims
- 4867US6803468B2Process for the synthesis of n-(5-methylnicontinoyl)-4 hydroxypiperidine, a key intermediate of rupatadineRANBAXY LAB LTD·Filed 2001·Granted Oct 12, 2004·3 cites·26 claims
- 4967US6590085B1Derivatives of monosaccharides as cell adhesion inhibitorsRANBAXY LAB LTD·Filed 1999·Granted Jul 8, 2003·20 cites·3 claims
- 5067US5869649AProcess for producing cephalosporin antibioticsRANBAXY LAB LTD·Filed 1996·Granted Feb 9, 1999·13 cites·14 claims
Showing the top 50 of 199 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →